Geode Capital Management’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.62M | Buy |
112,138
+99,016
| +755% | +$2.31M | ﹤0.01% | 3050 |
|
2025
Q1 | $200K | Buy |
13,122
+561
| +4% | +$8.54K | ﹤0.01% | 3850 |
|
2024
Q4 | $231K | Sell |
12,561
-1
| -0% | -$18 | ﹤0.01% | 3861 |
|
2024
Q3 | $139K | Sell |
12,562
-568
| -4% | -$6.3K | ﹤0.01% | 4012 |
|
2024
Q2 | $122K | Sell |
13,130
-15,248
| -54% | -$142K | ﹤0.01% | 4081 |
|
2024
Q1 | $930K | Buy |
28,378
+351
| +1% | +$11.5K | ﹤0.01% | 3390 |
|
2023
Q4 | $750K | Buy |
28,027
+1,003
| +4% | +$26.8K | ﹤0.01% | 3459 |
|
2023
Q3 | $1.63M | Buy |
27,024
+1,071
| +4% | +$64.8K | ﹤0.01% | 3142 |
|
2023
Q2 | $2.64M | Buy |
25,953
+1,166
| +5% | +$119K | ﹤0.01% | 3025 |
|
2023
Q1 | $4.38M | Buy |
24,787
+972
| +4% | +$172K | ﹤0.01% | 2691 |
|
2022
Q4 | $9.21M | Buy |
23,815
+1,032
| +5% | +$399K | ﹤0.01% | 2320 |
|
2022
Q3 | $7.68M | Buy |
22,783
+54
| +0.2% | +$18.2K | ﹤0.01% | 2431 |
|
2022
Q2 | $7.47M | Buy |
22,729
+378
| +2% | +$124K | ﹤0.01% | 2454 |
|
2022
Q1 | $9.78M | Sell |
22,351
-1,011
| -4% | -$442K | ﹤0.01% | 2358 |
|
2021
Q4 | $10.2M | Buy |
23,362
+108
| +0.5% | +$47.4K | ﹤0.01% | 2431 |
|
2021
Q3 | $12.9M | Buy |
23,254
+1,242
| +6% | +$691K | ﹤0.01% | 2273 |
|
2021
Q2 | $11.3M | Buy |
22,012
+1,958
| +10% | +$1.01M | ﹤0.01% | 2375 |
|
2021
Q1 | $15.7M | Buy |
20,054
+1,279
| +7% | +$1,000K | ﹤0.01% | 2032 |
|
2020
Q4 | $10.2M | Buy |
18,775
+860
| +5% | +$468K | ﹤0.01% | 2171 |
|
2020
Q3 | $8.21M | Buy |
17,915
+366
| +2% | +$168K | ﹤0.01% | 2074 |
|
2020
Q2 | $10.8M | Buy |
17,549
+649
| +4% | +$400K | ﹤0.01% | 1891 |
|
2020
Q1 | $8.04M | Buy |
16,900
+1,887
| +13% | +$897K | ﹤0.01% | 1871 |
|
2019
Q4 | $8.71M | Buy |
15,013
+422
| +3% | +$245K | ﹤0.01% | 2109 |
|
2019
Q3 | $9.6M | Buy |
14,591
+2,192
| +18% | +$1.44M | ﹤0.01% | 1968 |
|
2019
Q2 | $9.6M | Buy |
12,399
+1,345
| +12% | +$1.04M | ﹤0.01% | 1988 |
|
2019
Q1 | $7.81M | Buy |
11,054
+823
| +8% | +$581K | ﹤0.01% | 2058 |
|
2018
Q4 | $4.79M | Buy |
10,231
+574
| +6% | +$269K | ﹤0.01% | 2250 |
|
2018
Q3 | $8.33M | Buy |
9,657
+2,714
| +39% | +$2.34M | ﹤0.01% | 2050 |
|
2018
Q2 | $4.79M | Buy |
6,943
+580
| +9% | +$400K | ﹤0.01% | 2351 |
|
2018
Q1 | $2.84M | Buy |
6,363
+91
| +1% | +$40.5K | ﹤0.01% | 2575 |
|
2017
Q4 | $2.76M | Buy |
6,272
+93
| +2% | +$41K | ﹤0.01% | 2575 |
|
2017
Q3 | $3.05M | Buy |
6,179
+102
| +2% | +$50.3K | ﹤0.01% | 2496 |
|
2017
Q2 | $3.37M | Buy |
6,077
+907
| +18% | +$503K | ﹤0.01% | 2423 |
|
2017
Q1 | $3.42M | Buy |
5,170
+245
| +5% | +$162K | ﹤0.01% | 2343 |
|
2016
Q4 | $1.65M | Buy |
4,925
+1,166
| +31% | +$390K | ﹤0.01% | 2737 |
|
2016
Q3 | $1.13M | Buy |
3,759
+448
| +14% | +$135K | ﹤0.01% | 2875 |
|
2016
Q2 | $573K | Buy |
3,311
+87
| +3% | +$15.1K | ﹤0.01% | 3168 |
|
2016
Q1 | $721 | Buy |
3,224
+59
| +2% | +$13 | ﹤0.01% | 3049 |
|
2015
Q4 | $1.92M | Buy |
3,165
+46
| +1% | +$27.9K | ﹤0.01% | 2512 |
|
2015
Q3 | $1.6M | Buy |
3,119
+1,396
| +81% | +$718K | ﹤0.01% | 2580 |
|
2015
Q2 | $753K | Buy |
1,723
+247
| +17% | +$108K | ﹤0.01% | 3035 |
|
2015
Q1 | $533K | Buy |
1,476
+161
| +12% | +$58.1K | ﹤0.01% | 3170 |
|
2014
Q4 | $471K | Buy |
1,315
+74
| +6% | +$26.5K | ﹤0.01% | 3219 |
|
2014
Q3 | $374K | Buy |
1,241
+392
| +46% | +$118K | ﹤0.01% | 3291 |
|
2014
Q2 | $520K | Buy |
849
+11
| +1% | +$6.74K | ﹤0.01% | 3150 |
|
2014
Q1 | $561K | Buy |
+838
| New | +$561K | ﹤0.01% | 3102 |
|